Y10T436/204998

Hydrogel bead, chemical sensor including the same, container and electronic article including the chemical sensor

Disclosed herein are a hydrogel bead, a chemical sensor including the same, and an electronic product including the chemical sensor. The hydrogel bead includes at least one type of polysaccharide physically crosslinked with a cation or an anion, and a pH indicator dye.

Control of n-(phosphonomethyl)iminodiacetic acid conversion in manufacture of glyphosate

This invention relates to the preparation of N-(phosphonomethyl)glycine (“glyphosate”) from N-(phosphonomethyl)iminodiacetic acid (“PMIDA”), and more particularly to methods for control of the conversion of PMIDA, for the identification of reaction end points relating to PMIDA conversion and the preparation of glyphosate products having controlled PMIDA content. One such method involves obtaining a series of Fourier transform infrared (“FTIR”) analyses of the PMIDA content of the aqueous reaction medium or a sample thereof during the course of the reaction. From a plurality of FTIR analyses, a projection is made of the batch reaction time or continuous oxidation residence time within the oxidation reaction zone at which a target conversion or end point may be anticipated to be attained or is attained.

SODIUM NITRITE-CONTAINING PHARMACEUTICAL COMPOSITIONS

Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.

Sodium nitrite-containing pharmaceutical compositions

Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.

Sodium nitrite-containing pharmaceutical compositions

Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.

HYDROGEL BEAD, CHEMICAL SENSOR INCLUDING THE SAME, CONTAINER AND ELECTRONIC ARTICLE INCLUDING THE CHEMICAL SENSOR

Disclosed herein are a hydrogel bead, a chemical sensor including the same, and an electronic product including the chemical sensor. The hydrogel bead includes at least one type of polysaccharide physically crosslinked with a cation or an anion, and a pH indicator dye.

SODIUM NITRITE-CONTAINING PHARMACEUTICAL COMPOSITIONS

Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.

METHOD FOR MEASURING CARBOHYDRATE METABOLISM ABILITY, AND COMPOSITION FOR USE IN SAID METHOD

This invention provides a method for measuring glucose metabolism ability of a subject and a composition that is suitably used in the method. The method for measuring glucose metabolism ability of the present invention is as follows: a method for measuring glucose metabolism ability of a subject, using a composition for measuring glucose metabolism ability, the composition comprising, as an active ingredient, glucose labeled with at least one isotope of C, wherein the glucose is converted in the body into labeled carbon dioxide that is excreted in expired air, the method comprising steps (a) and (b) below: (a) administering the composition to the subject and collecting expired air; and (b) determining the ratio of labeled CO.sub.2 amount to unlabeled CO.sub.2 amount or the ratio of labeled CO.sub.2 amount to total CO.sub.2 amount.

SODIUM NITRITE-CONTAINING PHARMACEUTICAL COMPOSITIONS

Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.

METHODS, DEVICES, SYSTEMS, AND COMPOSITIONS FOR DETECTING GASES

A method of monitoring a respiratory stream can be provided by monitoring color change of a color change material to determine a CO2 level of the respiratory stream in contact with the color change material by emitting visible light onto the color change material. Related devices, systems, and compositions are also disclosed.